Women Clear Winners with Heart Fail... (the MADIT-CRT trial researchers followed...)

Women Clear Winners with Heart Failure Device

Date:5/13/2010

the MADIT-CRT trial researchers followed 1,820 participants from 110 medical centers in the United States, Canada and Europe for four-and-one-half years to compare the effectiveness of ICD versus CRT-D therapy in reducing heart failure and death. Twenty-five percent, or 453 of the study participants, were female. The purpose of the sub-analysis was to explore the factors associated with the more favorable response to CRT-D therapy in women than men.

Moss is leading several follow-up studies that will track participants from the MADIT-CRT trial over longer periods of time to further gauge reductions in heart failure, effects of CRT-D therapy on quality of life, and overall treatment costs.

The current study was a joint effort between Boston Scientific, St. Luke's and Roosevelt Hospitals and Columbia University College of Physicians & Surgeons, and the University of Rochester Medical Center. Moss received honoraria from Boston Scientific prior to 2009 for talks at scientific programs. He holds no stock in any device company, has never been a member of any corporate speakers' bureau, and since Dec. 1, 2008, has chosen not to accept honoraria from Boston Scientific for any professional activity.

One of the nation's top academic medical centers, the University of Rochester Medical Center (http://www.urmc.rochester.edu) forms the centerpiece of the University's health research, teaching, patient care, and community outreach missions. The M
'/>"/>

SOURCE University of Rochester Medical Center
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Womens Empowerment Icons Commemorate the 50th Anniversary of the Pill
2. Roche Women Honored as 2010 TWIN Awardees
3. Center for Fertility Preservation Uses Breakthrough Egg Freezing Technology to Offer Women a Viable Backup Plan
4. Aurora Womens Pavilion Center for Sexual Health & Wellness Receives Grant to Treat Vulvar Pain
5. President of Pfizer Vaccines, Mark Swindell, Named as the Healthcare Businesswomens Associations 2010 Honorable Mentor
6. GlaxoSmithKline President of North America Pharmaceuticals, Deirdre Connelly, Named 2010 Woman of the Year by the Healthcare Businesswomens Association
7. The Womens Heart Foundation Presents the Womens Heart Advocate Award for Medicine and Science to Multifunction CardioGram(TM) Inventor Dr. Joseph T. Shen
8. Pamela Prince-Eason Named Chair Of Board Of Directors For Womens Business Enterprise National Council
9. Awareness of Heart Disease in Women Remains Low
10. Womens Digital Imaging Using DXA Total Body Fat Analysis to Help Patients in Weight Management and Fitness Programs
11. Cryo-Cell CEO Mercedes Walton Invites Women to Share Their Ideas on Self-Care and the Power of Stem Cells

Post Your Comments:

(Date:5/23/2013)... BioElectronics Corporation (OTC Pink: BIEL), the maker of ... FDA panel meeting for non-thermal shortwave diathermy: ... Therapy Meeting was held on May 21, 2013 in ... of the meeting was very narrow, in that the ... the application of non-thermal shortwave diathermy for the treatment ...

(Date:5/23/2013)... Conn. , May 23, 2013 CAS Medical Systems, ... medical devices for non-invasive patient monitoring, today announced that ... Officer, will present at the 2 nd Annual Marcum ... Hyatt Hotel in New York City . ... p.m. ET in the Estate 10 room and will be ...

(Date:5/23/2013)... , May 23, 2013 Halozyme ... announced the appointment of David A. ... Ramsay was most recently Vice President, Corporate Development ... ) "With his established financial management ... gained by working in our commercial group for ...

Breaking Medicine Technology:BioElectronics and Pulsed Shortwave Therapy Make Progress 2 CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2 Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2

[0] BioElectronics and Pulsed Shortwave Therapy Make Progress [0] CASMED to Present at the 2nd Annual Marcum MicroCap Conference [0] Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer

... May 21 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader ... Citi Investment Research,s 2010 Global Health Care Conference on Thursday, May 27, ... Hotel. , , , ... the presentation will be available on the "Investors & Media" section of the ...

... Sorrento Therapeutics, Inc. (OTC Bulletin Board: SRNE) ... Small Business Technology Transfer Research (STTR) grant from the ... grant was awarded to support the Company,s program to ... combat Staphylococcus aureus ( S. aureus ...

Cached Medicine Technology:Isis Pharmaceuticals to Present at the 2010 Citi Investment Research Global Health Care Conference 2 Sorrento Therapeutics Awarded NIH Grant for MRSA Program 2 Sorrento Therapeutics Awarded NIH Grant for MRSA Program 3 Sorrento Therapeutics Awarded NIH Grant for MRSA Program 4

Isis Pharmaceuticals to Present at the 2010 Citi Investment Research Global Health Care Conference Sorrento Therapeutics Awarded NIH Grant for MRSA Program

(Date:5/23/2013)... FL (PRWEB) May 23, 2013 ... regenerative medicine company focused on the commercialization of ... and regeneration, today announced that the Company and ... million grant, for which AxoGen’s portion is approximately ... administrated by the U.S. Department of Defense (DoD) ...

(Date:5/23/2013)... 2013 Hile Design LLC is pleased ... awarded a Silver Creative Award at the Summit International ... entry was for its “Open Doors” animation promoting Scio ... in the 2013 District 6 ADDY Awards for the ... Creative Award recognizes and celebrates the creative achievements of ...

(Date:5/23/2013)... Utah (PRWEB) May 23, 2013 Registered ... R.D., published an article today on Tatalou.com offering helpful ... vacation. , The article, titled “ How to Stay ... important to carry hand sanitizer, when it’s safe to ... out for seafood, the importance of staying hydrated and ...

(Date:5/23/2013)... OH and Durham, NC (PRWEB) May 23, 2013 ... and commercialization firm that funds and develops innovative ... Deep Brain Innovations, LLC (DBI). DBI will ... optimize deep brain stimulation (DBS) therapy for patients ... is effective in treating Parkinson’s disease and generates ...

(Date:5/23/2013)... Consortium, Ltd., issued the following statement today on ... Reform of chemical safety legislation will succeed only ... Ensuring the safety and appropriate use of chemicals ... Toxic Substances Control Act is a critical opportunity ... transforming toxicity testing "from a system based on ...

Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense 2 Health News:AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense 3 Health News:How to Stay Healthy While Traveling 2 Health News:NDI Launches Deep Brain Innovations, LLC 2 Health News:NDI Launches Deep Brain Innovations, LLC 3

[0] AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense [0] Hile Design Wins Silver Creative Award at the 2013 Summit Internationals [0] How to Stay Healthy While Traveling [0] NDI Launches Deep Brain Innovations, LLC [0] Chemical Safety Improvement Act of 2013: PETA International Science Consortium

... global research,organization, announced that it has appointed new staff ... Resourcing Solutions,division. Maria Sanchez Garcia will lead the group ... whilst Hannah King joins our United,Kingdom team to focus ... very pleased to help in the continued growth of ...

... deal demonstrates commitment to dermatology and innovation, ... Stiefel Laboratories, Inc.,the world,s largest independent pharmaceutical ... has completed its previously announced,acquisition of Princeton, ... of the acquisition, all remaining outstanding shares ...

... Call and Webcast Scheduled for August 7, 2008 ... Aug. 6 The Ensign,Group, Inc. (Nasdaq: ... group of,skilled nursing, rehabilitative care services and assisted ... quarter of fiscal,year 2008., (Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ...

... ... Diluted FAD ... Second Quarter Investments $250 Million, NEWPORT BEACH, Calif., ... operations,and investment activity for the second quarter and the six months ended,June 30, 2008., ...

... put themselves at increased risk for second malignancies , , ... British adults who survived childhood cancers currently smoke, while ... in their lives, a new study reports. , ... cancer have a greater chance of developing cardiovascular disease, ...

... Aug. 6 AMN Healthcare Services,Inc. (NYSE: AHS ... leader in all of its business segments today reported ... quarter last year and a 7%,increase from last quarter. ... Nurse & Allied, Locum Tenens and,Physician Permanent Placement, experienced ...

Chiltern's Resourcing Solutions Division Appoints New Managers to Spain and the United Kingdom Stiefel Laboratories Completes Acquisition of Barrier Therapeutics The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance NHP Reports Second Quarter 2008 Earnings One-Fifth of British Childhood Cancer Survivors Smoke AMN Healthcare Reports Second Quarter 2008 Results

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

Medicine Products:

Lyme Antibodies, Total (CSF)Luteinizing Hormone, Pooled Lupus Anticoagulant Panel with Reflex to 1:1 Mixes & Confirmations Lupus Erythematous, Tissue